Morita Katsuya, Sakakibara Akira, Kitayama Shigeo, Kumagai Kei, Tanne Kazuo, Dohi Toshihiro
Department of Dental Pharmacology, Division of Integrated Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan.
J Pharmacol Exp Ther. 2002 Sep;302(3):972-82. doi: 10.1124/jpet.102.033456.
Characteristics of pituitary adenylate cyclase-activating polypeptide (PACAP)-induced increase of Ca(2+) entry and catecholamine (CA) release were studied in bovine adrenal medullary chromaffin cells. PACAP induced intracellular free Ca(2+) concentration (Ca(2+)), showing an initial transient Ca(2+) rise followed by a sustained rise and CA release, which were not blocked by the blocking agents for nicotinic acetylcholine receptor (nAChR) channel, the voltage-dependent Ca(2+) channel (VOC), or the Na(+) channel. The sarcoendoplasmic Ca(2+)-ATPase inhibitors thapsigargin and cyclopiazonic acid did not affect the PACAP-induced sustained rise of Ca(2+), but did inhibit the initial Ca(2+) rise. In cells pretreated with cyclopiazonic acid or membrane-permeable, low-affinity Ca(2+) chelator N',N',N',N'-tetrakis(2-pyridylmethyl)ethylenediamine, PACAP further stimulated the entry of Ca(2+) or Mn(2+), whereas these treatments masked Ca(2+) dynamics induced by bradykinin. PACAP-induced sustained Ca(2+) rise and Mn(2+) entry were enhanced by acidic extracellular solution and reduced by alkalinization, whereas thapsigargin-induced Mn(2+) entry was regulated by the opposite. PACAP-induced Ca(2+) rise and Mn(2+) entry were not affected by blockers of cAMP-dependent protein kinase, phospholipase C, or protein kinase C. All store-operated Ca(2+) channel (SOC) blocking agents tested inhibited thapsigargin-induced Mn(2+) entry. 1(beta-[3-(4-Methoxyphenyl)-propoxy]-4-methoxyphenylethyl)-1H-imidazole hydrochloride (SK&F 96365), (R,S)-(3,4-dihydro-6,7-dimethoxy-isoquinoline-1-yl)-2-phenyl-N,N-di-[2-(2,3,4-trimethoxyphenyl)ethyl]-acetamide, and econazole inhibited PACAP-induced Ca(2+) or Mn(2+) entry, whereas GdCl(3), 7,8-benzoflavone, nor-dihydroguaiaretic acid, 5-nitro-2-(3-phenylpropylamino)benzoic acid, fulfenamic acid, and niflumic acid did not. SK&F 96365 and econazole but not GdCl(3) inhibited PACAP-induced CA release. These results suggest that PACAP activates a novel Ca(2+) entry pathway associated with sustained CA release independent of the nAChR channel, VOC and SOC, activated by acid pH, with different sensitivity to blockers of SOC. This pathway may provide a useful model for the study of receptor-operated Ca(2+) entry.
在牛肾上腺髓质嗜铬细胞中研究了垂体腺苷酸环化酶激活多肽(PACAP)诱导的Ca(2+)内流增加和儿茶酚胺(CA)释放的特性。PACAP诱导细胞内游离Ca(2+)浓度([Ca(2+)]i)升高,表现为[Ca(2+)]i先出现短暂升高,随后持续升高以及CA释放,而这些现象并未被烟碱型乙酰胆碱受体(nAChR)通道、电压依赖性Ca(2+)通道(VOC)或Na(+)通道的阻断剂所阻断。肌浆内质网Ca(2+)-ATP酶抑制剂毒胡萝卜素和环匹阿尼酸不影响PACAP诱导的[Ca(2+)]i持续升高,但能抑制[Ca(2+)]i的初始升高。在用环匹阿尼酸或膜通透性低亲和力Ca(2+)螯合剂N',N',N',N'-四(2-吡啶甲基)乙二胺预处理的细胞中,PACAP进一步刺激Ca(2+)或Mn(2+)内流,而这些处理掩盖了缓激肽诱导的[Ca(2+)]i动态变化。酸性细胞外溶液增强了PACAP诱导的[Ca(2+)]i持续升高和Mn(2+)内流,而碱化则使其降低,而毒胡萝卜素诱导的Mn(2+)内流受相反调节。PACAP诱导的[Ca(2+)]i升高和Mn(2+)内流不受cAMP依赖性蛋白激酶、磷脂酶C或蛋白激酶C阻断剂的影响。所有测试的储存操纵性Ca(2+)通道(SOC)阻断剂均抑制毒胡萝卜素诱导的Mn(2+)内流。1(beta-[3-(4-甲氧基苯基)-丙氧基]-4-甲氧基苯乙基)-1H-咪唑盐酸盐(SK&F 96365)、(R,S)-(3,4-二氢-6,7-二甲氧基-异喹啉-1-基)-2-苯基-N,N-二-[2-(2,3,4-三甲氧基苯基)乙基]-乙酰胺和益康唑抑制PACAP诱导的Ca(2+)或Mn(2+)内流,而GdCl(3)、7,8-苯并黄酮、去氢二咖啡酸、5-硝基-2-(3-苯丙基氨基)苯甲酸、氟灭酸和尼氟酸则无此作用。SK&F 96365和益康唑而非GdCl(3)抑制PACAP诱导的CA释放。这些结果表明,PACAP激活了一条与持续CA释放相关的新型Ca(2+)内流途径,该途径独立于nAChR通道、VOC和SOC,受酸性pH激活,对SOC阻断剂具有不同的敏感性。该途径可能为研究受体操纵性Ca(2+)内流提供一个有用的模型。